NCT06306742

Brief Summary

to investigate the effects of placebo in patients affected by low-back pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Feb 2024

Shorter than P25 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 26, 2024

Completed
3 days until next milestone

First Submitted

Initial submission to the registry

February 29, 2024

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 12, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 18, 2025

Completed
Last Updated

August 11, 2025

Status Verified

March 1, 2024

Enrollment Period

1.3 years

First QC Date

February 29, 2024

Last Update Submit

August 5, 2025

Conditions

Keywords

PlaceboPlacebo effectOpen-label trial

Outcome Measures

Primary Outcomes (2)

  • Change in Numeric Rating Scale

    a verbal determination of a pain level on a scale from 0 to 10, in which 0 represents no pain and 10 represents excruciating pain.

    Change from baseline of numeric rating scale at week 2, 4 and 8.

  • Adverse effects

    Number and types of adverse effects occurred after intervention

    through study completion (8 weeks)

Secondary Outcomes (3)

  • Change in measures of Von Frey filaments

    from baseline at week 2,4 and 8.

  • Changes in algometer measurements

    from baseline at week 2, 4 and 8

  • Use of analgesics

    The week before the scheduled visit.

Study Arms (3)

OMT

ACTIVE COMPARATOR

Participants will receive manual treatments. The treatment will include soft-tissue, joint mobilization techniques of the lumbar and sacral region. The treatment will also include the approach of the abdomen and lower limb with the same type of techniques. Four treatments will be provided at 1, 2, 4 and 8 weeks.

Other: Osteopathic manipulative treatment

Open-label placebo

EXPERIMENTAL

This group will receive an open-label placebo. The manual treatment will be performed in the same areas of the active comparator but using a very light pressure. Additionally, before the start of the treatment, Four treatments will be provided at 1, 2, 4 and 8 weeks.

Other: Open-label placebo

Waiting list

NO INTERVENTION

Participants will receive no treatment.

Interventions

Light pressure manual therapy

Open-label placebo

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (+18 years) who complain of chronic non-specific low back pain for at least 3 months with or without pain exacerbations at the time of recruitment, will be included.
  • Patients will need to have a diagnosis of low back pain made by a physician

You may not qualify if:

  • pathologies such as ankylosing spondylitis, infections, fractures, tumors or metastases.
  • Pregnant women
  • patients with previous spinal surgery or undergoing cortisone therapy in the 6 months prior to the trial
  • diseases that may affect the interpretation of results such as fibromyalgia
  • patients currently being treated by other specialists or other manual therapists

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CTFO

Saronno, Varese, 21047, Italy

Location

MeSH Terms

Conditions

Low Back Pain

Interventions

Manipulation, Osteopathic

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

February 29, 2024

First Posted

March 12, 2024

Study Start

February 26, 2024

Primary Completion

June 18, 2025

Study Completion

June 18, 2025

Last Updated

August 11, 2025

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations